Transmigration characteristics of breast cancer and melanoma cells through the brain endothelium: Role of Rac and PI3K

References

• Lorger M, Felding-Habermann B. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am J Pathol 2010; 176:2958-71; PMID:20382702; http://dx.doi.org/10.2353/ajpath.2010.090838
   PubMed Web of Science ®Google Scholar
• Wilhelm I, Molnar J, Fazakas C, Hasko J, Krizbai IA. Role of the blood-brain barrier in the formation of brain metastases. Int J Mol Sci 2013; 14:1383; PMID:23344048; http://dx.doi.org/10.3390/ijms14011383
   PubMed Web of Science ®Google Scholar
• Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ, Chaft JE, Kris MG, Huse JT, Brogi E, et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 2014; 156:1002-16; PMID:24581498; http://dx.doi.org/10.1016/j.cell.2014.01.040
   PubMed Web of Science ®Google Scholar
• Bugyik E, Dezso K, Reiniger L, László V, Tóvári J, Tímár J, Nagy P, Klepetko W, Döme B, Paku S. Lack of angiogenesis in experimental brain metastases. J Neuropathol Exp Neurol 2011; 70:979-91; PMID:22002424; http://dx.doi.org/10.1097/NEN.0b013e318233afd7
   PubMed Web of Science ®Google Scholar
• Kim SW, Choi HJ, Lee HJ, He J, Wu Q, Langley RR, Fidler IJ, Kim SJ. Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells. Neuro Oncol 2014; 16:1585-98; PMID:25008093; http://dx.doi.org/10.1093/neuonc/nou128
   PubMed Web of Science ®Google Scholar
• Hamilla SM, Stroka KM, Aranda-Espinoza H. VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration. PLoS One 2014; 9:e109748; PMID:25275457; http://dx.doi.org/10.1371/journal.pone.0109748
   PubMedGoogle Scholar
• Wilhelm I, Krizbai IA. In vitro models of the blood-brain barrier for the study of drug delivery to the brain. Mol Pharm 2014; 11:1949-63; PMID:24641309; http://dx.doi.org/10.1021/mp500046f
   PubMed Web of Science ®Google Scholar
• Fazakas C, Wilhelm I, Nagyoszi P, Farkas AE, Hasko J, Molnar J, Bauer H, Bauer HC, Ayaydin F, Dung NT, et al. Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases. PloS One 2011; 6:e20758; PMID:21674054; http://dx.doi.org/10.1371/journal.pone.0020758
   PubMed Web of Science ®Google Scholar
• Khuon S, Liang L, Dettman RW, Sporn PH, Wysolmerski RB, Chew TL. Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study. J Cell Sci 2010; 123:431-40; PMID:20067998; http://dx.doi.org/10.1242/jcs.053793
   PubMed Web of Science ®Google Scholar
• Arvanitis C, Khuon S, Spann R, Ridge KM, Chew TL. Structure and biomechanics of the endothelial transcellular circumferential invasion array in tumor invasion. PLoS One 2014; 9:e89758; PMID:24587014; http://dx.doi.org/10.1371/journal.pone.0089758
   PubMedGoogle Scholar
• Wilhelm I, Fazakas C, Molnar J, Hasko J, Vegh AG, Cervenak L, Nagyőszi P, Nyúl-Tóth A, Farkas AE, Bauer H, et al. Role of Rho/ROCK signaling in the interaction of melanoma cells with the blood-brain barrier. Pigment Cell Melanoma Res 2014; 27:113; PMID:24148763; http://dx.doi.org/10.1111/pcmr.12169
   PubMed Web of Science ®Google Scholar
• Parri M, Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 2010; 8:23; PMID:20822528; http://dx.doi.org/10.1186/1478-811X-8-23
   PubMed Web of Science ®Google Scholar
• Symons M, Segall JE. Rac and Rho driving tumor invasion: who's at the wheel? Genome Biol 2009; 10:213; PMID:19291272; http://dx.doi.org/10.1186/gb-2009-10-3-213
   PubMed Web of Science ®Google Scholar
• Wertheimer E, Gutierrez-Uzquiza A, Rosemblit C, Lopez-Haber C, Sosa MS, Kazanietz MG. Rac signaling in breast cancer: a tale of GEFs and GAPs. Cell Signal 2012; 24:353-62; PMID:21893191; http://dx.doi.org/10.1016/j.cellsig.2011.08.011
   PubMed Web of Science ®Google Scholar
• Ebi H, Costa C, Faber AC, Nishtala M, Kotani H, Juric D, Della Pelle P, Song Y, Yano S, Mino-Kenudson M, et al. PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1. Proc Natl Acad Sci U S A 2013; 110:21124-9; PMID:24327733; http://dx.doi.org/10.1073/pnas.1314124110
   PubMed Web of Science ®Google Scholar
• Akinleye A, Avvaru P, Furqan M, Song Y, Liu D. Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics. J Hematol Oncol 2013; 6:88; PMID:24261963; http://dx.doi.org/10.1186/1756-8722-6-88
   PubMed Web of Science ®Google Scholar
• Liu P, Cheng H, Roberts TM, Zhao JJ. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 2009; 8:627-44; PMID:19644473; http://dx.doi.org/10.1038/nrd2926
   PubMed Web of Science ®Google Scholar
• Schlegel NC, von Planta A, Widmer DS, Dummer R, Christofori G. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells. Exp Dermatol 2015; 24:22-8; PMID:25363503; http://dx.doi.org/10.1111/exd.12580
   PubMed Web of Science ®Google Scholar
• Sadeghi N, Gerber DE. Targeting the PI3K pathway for cancer therapy. Future Med Chem 2012; 4:1153-69; PMID:22709255; http://dx.doi.org/10.4155/fmc.12.56
   PubMed Web of Science ®Google Scholar
• Welf ES, Ahmed S, Johnson HE, Melvin AT, Haugh JM. Migrating fibroblasts reorient directionality by a metastable, PI3K-dependent mechanism. J Cell Biol 2012; 197:105-14; PMID:22472441; http://dx.doi.org/10.1083/jcb.201108152
   PubMed Web of Science ®Google Scholar
• Fidler IJ, Schackert G, Zhang RD, Radinsky R, Fujimaki T. The biology of melanoma brain metastasis. Cancer Metastasis Rev 1999; 18:387; PMID:10721492; http://dx.doi.org/10.1023/A:1006329410433
   PubMed Web of Science ®Google Scholar
• Denkins Y, Reiland J, Roy M, Sinnappah-Kang ND, Galjour J, Murry BP, Blust J, Aucoin R, Marchetti D. Brain metastases in melanoma: roles of neurotrophins. Neuro Oncol 2004; 6:154-65; PMID:15134630; http://dx.doi.org/10.1215/S115285170300067X
   PubMed Web of Science ®Google Scholar
• Rozenberg GI, Monahan KB, Torrice C, Bear JE, Sharpless NE. Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation. Melanoma Res 2010; 20:361-71; PMID:20679910
   PubMed Web of Science ®Google Scholar
• Boussemart L, Malka-Mahieu H, Girault I, Allard D, Hemmingsson O, Tomasic G, Thomas M, Basmadjian C, Ribeiro N, Thuaud F, et al. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies. Nature 2014; 513:105-9; PMID:25079330; http://dx.doi.org/10.1038/nature13572
   PubMed Web of Science ®Google Scholar
• Safuan S, Storr SJ, Patel PM, Martin SG. A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endothelium. Lymphat Res Biol 2012; 10:173-81; PMID:23215743; http://dx.doi.org/10.1089/lrb.2012.0007
   PubMed Web of Science ®Google Scholar
• Davies MA, Stemke-Hale K, Lin E, Tellez C, Deng W, Gopal YN, Woodman SE, Calderone TC, Ju Z, Lazar AJ, et al. Integrated molecular and clinical analysis of AKT activation in metastatic melanoma. Clin Cancer Res 2009; 15:7538; PMID:19996208; http://dx.doi.org/10.1158/1078-0432.CCR-09-1985
   PubMed Web of Science ®Google Scholar
• Xing F, Persaud Y, Pratilas CA, Taylor BS, Janakiraman M, She QB, Gallardo H, Liu C, Merghoub T, Hefter B, et al. Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF. Oncogene 2012; 31:446-57; PMID:21725359; http://dx.doi.org/10.1038/onc.2011.250
   PubMed Web of Science ®Google Scholar
• Peng HH, Hodgson L, Henderson AJ, Dong C. Involvement of phospholipase C signaling in melanoma cell-induced endothelial junction disassembly. Front Biosci 2005; 10:1597-606; PMID:15769649; http://dx.doi.org/10.2741/1643
   PubMed Web of Science ®Google Scholar
• Niessner H, Forschner A, Klumpp B, Honegger JB, Witte M, Bornemann A, Dummer R, Adam A, Bauer J, Tabatabai G, et al. Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases. Cancer Med 2013; 2:76-85; PMID:24133630; http://dx.doi.org/10.1002/cam4.50
   PubMed Web of Science ®Google Scholar
• Li B, Zhao WD, Tan ZM, Fang WG, Zhu L, Chen YH. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett 2006; 580:4252-60; PMID:16828752; http://dx.doi.org/10.1016/j.febslet.2006.06.056
   PubMed Web of Science ®Google Scholar
• Mierke CT. Cancer cells regulate biomechanical properties of human microvascular endothelial cells. J Biol Chem 2011; 286:40025-37; PMID:21940631; http://dx.doi.org/10.1074/jbc.M111.256172
   PubMed Web of Science ®Google Scholar
• Campa CC, Ciraolo E, Ghigo A, Germena G, Hirsch E. Crossroads of PI3K and Rac pathways. Small GTPases 2015; 6:71-80; PMID:25942647; http://dx.doi.org/10.4161/21541248.2014.989789
   PubMedGoogle Scholar
• Rodon J, Dienstmann R, Serra V, Tabernero J. Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol 2013; 10:143-53; PMID:23400000; http://dx.doi.org/10.1038/nrclinonc.2013.10
   PubMed Web of Science ®Google Scholar
• Wilhelm I, Farkas AE, Nagyoszi P, Váró G, Bálint Z, Végh GA, Couraud PO, Romero IA, Weksler B, Krizbai IA. Regulation of cerebral endothelial cell morphology by extracellular calcium. Phys Med Biol 2007; 52:6261-74; PMID: 17921584; http://dx.doi.org/10.1088/0031-9155/52/20/012
   PubMed Web of Science ®Google Scholar
• Qin D, Xia Y, Whitesides GM. Soft lithography for micro- and nanoscale patterning. Nat Protoc 2010; 5:491-502; PMID:20203666; http://dx.doi.org/10.1038/nprot.2009.234
   PubMed Web of Science ®Google Scholar
• Song JW, Gu W, Futai N, Warner KA, Nor JE, Takayama S. Computer-controlled microcirculatory support system for endothelial cell culture and shearing. Anal Chem 2005; 77:3993-9; PMID:15987102; http://dx.doi.org/10.1021/ac050131o
   PubMed Web of Science ®Google Scholar